Citius Pharmaceuticals CTXR
NASDAQ CTXR
$0.40 +0.03 (+8.11%)
At close: Oct 23, 2026 · 4:00 PM EDT

Citius Pharmaceuticals (CTXR) Return on Sales [ROS] (2014 - 2026)

Updated

Citius Pharmaceuticals' Return on Sales [ROS] was -785.39% in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 1145.56 percentage points from the prior quarter.

Analysis

Citius Pharmaceuticals (CTXR) Return on Sales [ROS] (2014 - 2026) Analysis & Trends

On a trailing twelve-month basis, Citius Pharmaceuticals' Return on Sales [ROS] was -863.92% through Jun 30, 2026.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 24.35%
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 37.86%
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -3.52%
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 32.97%
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 20.57%
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 34.95%
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -133.21%
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 28.37%
10 Citius Pharmaceuticals 10.98 Mn -13.30 Mn 1.00 Mn -785.39%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -785.39%
Mar 31, 2026 -1,930.96%
Dec 31, 2025 -228.68%
Sep 30, 2016 -56,776,166.67%
Jun 30, 2016 -271,922.51%
Mar 31, 2016 -22,387,033.33%
Dec 31, 2015 -8,297,840.00%
Sep 30, 2015 -856,974.34%
Jun 30, 2015 -259,640.60%
Mar 31, 2015 -136,222.37%
Dec 31, 2014 -39,805.48%
API Access

Citius Pharmaceuticals Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CTXR&period=max&api_key=YOUR_API_KEY